Terminally differentiated ventricular muscle cells virtually cease to proliferate, and subsequent cardiac growth occurs almost exclusively by cell enlargement. Hence, failure to increase cell number preludes cardiac regeneration as a means to reconstitute functional mass after infarction or other insult. This irreversible growth arrest poses a therapeutic challenge, especially in the elderly, where the includes of infarction and heart failure is high. Using an array of recombinant viruses to direct the expression of adenoviral EIA proteins, the applicant has recently demonstrated evidence for dual pocket protein-and p300-dependent pathways that govern the cell cycle in cardiac muscle. Drawing on these developments the present application proposes to study in depth the endogenous occupant of the """"""""pocket"""""""", the transcription factor known as E2F; modulators of pocket protein function in the heart, known as cyclins and clyclin-dependent protein kinases (Cdks); and the molecular relationship between the pocket protein-and p300-dependent mechanisms.
Specific Aims of the present project are: (1) to establish molecular mechanisms for the phenotype effects of E2F ( activation of the cell cycle, and repression of tissue-specific genes) in cardiac muscle cells; (2) to clarify what role is played by endogenous regulators of free E2F (G1 cyclins, Cdks, and Cdk inhibitors) in cardiac muscle cells; (3) To determine the epistatic relationship between E2F and the p300 pathway in cardiac muscle cells; and (4) To investigate the function of E2F in adult cardiac muscle in vivo, by direct injection of e2F virus and by cardiac-restricted homologous recombination of the pocket protein gene, Rb.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL047567-09
Application #
6151280
Study Section
Cardiovascular and Pulmonary Research A Study Section (CVA)
Project Start
1992-02-01
Project End
2002-01-31
Budget Start
2000-02-01
Budget End
2001-01-31
Support Year
9
Fiscal Year
2000
Total Cost
$225,650
Indirect Cost
Name
Baylor College of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
MacLellan, W R; Garcia, A; Oh, H et al. (2005) Overlapping roles of pocket proteins in the myocardium are unmasked by germ line deletion of p130 plus heart-specific deletion of Rb. Mol Cell Biol 25:2486-97
MacLellan, W R; Xiao, G; Abdellatif, M et al. (2000) A novel Rb- and p300-binding protein inhibits transactivation by MyoD. Mol Cell Biol 20:8903-15
Akli, S; Zhan, S; Abdellatif, M et al. (1999) E1A can provoke G1 exit that is refractory to p21 and independent of activating cdk2. Circ Res 85:319-28
Charng, M J; Zhang, D; Kinnunen, P et al. (1998) A novel protein distinguishes between quiescent and activated forms of the type I transforming growth factor beta receptor. J Biol Chem 273:9365-8
Abdellatif, M; Packer, S E; Michael, L H et al. (1998) A Ras-dependent pathway regulates RNA polymerase II phosphorylation in cardiac myocytes: implications for cardiac hypertrophy. Mol Cell Biol 18:6729-36
Agah, R; Kirshenbaum, L A; Abdellatif, M et al. (1997) Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo. J Clin Invest 100:2722-8
MacLellan, W R; Schneider, M D (1997) Death by design. Programmed cell death in cardiovascular biology and disease. Circ Res 81:137-44
Abdellatif, M; Schneider, M D (1997) An effector-like function of Ras GTPase-activating protein predominates in cardiac muscle cells. J Biol Chem 272:525-33
Agah, R; Frenkel, P A; French, B A et al. (1997) Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J Clin Invest 100:169-79
Charng, M J; Kinnunen, P; Hawker, J et al. (1996) FKBP-12 recognition is dispensable for signal generation by type I transforming growth factor-beta receptors. J Biol Chem 271:22941-4

Showing the most recent 10 out of 25 publications